Berkeley, CA, United States of America

Amer M Mirza

This inventor holds 16 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Xoma Technology Ltd., Xoma (US) LLC, University of California. Active years: 2011-2026.

USPTO Granted Patents = 16 

% Patents Active = 87.5

 

 

Average Co-Inventor Count = 5.4

ph-index = 4

Forward Citations = 72(Granted Patents)


Location History:

  • Berkeley, CA (US) (2019)
  • Emeryville, CA (US) (2023)
  • San Francisco, CA (US) (2011 - 2024)

Company Filing History:


Years Active: 2011-2026

Loading Chart...
Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents

Title: The Innovative Journey of Amer M Mirza

Introduction: Amer M Mirza, a talented inventor based in Berkeley, CA, has made significant contributions to the field of technology with his groundbreaking innovations.

Latest Patents: Amer M Mirza holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing his diverse range of expertise and creativity.

Career Highlights: With a background in engineering and a passion for problem-solving, Amer M Mirza has successfully developed cutting-edge solutions that have revolutionized various industries. His commitment to innovation and excellence is evident in the numerous patents he has secured over the years.

Collaborations: Throughout his career, Amer M Mirza has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion: Amer M Mirza's relentless pursuit of innovation and his dedication to pushing the boundaries of technology make him a true pioneer in the world of inventions. His impact on the industry is profound, and his legacy as an inventor continues to inspire future generations of innovators.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…